| Disease Subtype(s) |
HCT Disease Inserts required |
Cellular Therapy Disease Inserts required |
|---|
- Atypical chronic myeloid leukemia (aCML), BCR-ABL1 (1440)
- Chronic myelomonocytic leukemia (CMMoL) (54)
- Myelodysplastic syndrome / myeloproliferative neoplasm, unclassifiable (69)
- MDS / MPN with ring sideroblasts and thrombocytosis (MDS / MPN-RS-T) (1452)
- Myelodysplastic syndrome (MDS), unclassifiable (50)
- Myelodysplastic syndrome with isolated del(5q) (66)
- Myelodysplastic syndrome with multilineage dysplasia (MDS-MLD) (64)
- Myelodysplastic syndrome with single lineage dysplasia (MDS-SLD) (51)
- Refractory cytopenia of childhood (68)
Myelodysplastic syndrome with excess blasts (MDS-EB)
- MDS with excess blasts-1 (MDS-EB-1) (61)
- MDS with excess blasts-2 (MDS-EB-2) (62)
Myelodysplastic syndrome with ring sideroblasts (MDS-RS)
- MDS-RS with single lineage dysplasia (MDS-RS-SLD) (1453)
- MDS-RS with multilineage dysplasia (MDS-RS-MLD) (1454)
|
Forms 2014 & 2114 |
No disease inserts required |
| Disease Subtype(s) |
HCT Disease Inserts required |
Cellular Therapy Disease Inserts required |
|---|
- Juvenile myelomonocytic leukemia (JMML/JCML)(no evidence of Ph1 or BCR/ABL)(36)
|
Forms 2015 & 2115 |
No disease insert required |
Last modified:
Jul 28, 2021
